文献速递脑血管病

大血管闭塞急性缺血性卒中再通治疗的有效性与安全性:系统综述

Efficacy and Safety of Recanalization Therapy for Acute Ischemic Stroke With Large Vessel Occlusion: A Systematic Review.
PubMed 文献 · Stroke · 2020-06-03

该系统综述纳入17项试验共3236例大血管闭塞急性缺血性卒中患者,并检索到8项在研临床试验。网络荟萃分析显示,静脉溶栓联合机械取栓与更高的独立功能率相关;静脉溶栓在神经功能方面排名最差,直接机械取栓在全因死亡安全性方面排名最差。无论采用何种评估工具,血管内治疗联合静脉溶栓的成功再通率均高于单纯溶栓。

要点

  • 对大血管闭塞且适合溶栓的患者,静脉溶栓联合机械取栓可能是最有效策略,且不增加不良效应。
  • 静脉溶栓在神经功能结局方面排名最差,直接机械取栓在全因死亡安全性方面排名最差。
  • 血管内治疗联合静脉溶栓的成功再通率高于单纯溶栓,且不受评估工具影响。

核心结论

  • 与其它再通治疗相比,静脉溶栓联合机械取栓似乎是大血管闭塞急性缺血性卒中适合溶栓患者最有效的策略,且不增加不良效应。
  • 未来试验和真实世界研究应采用统一的有症状颅内出血和再通定义,以改善再通治疗的证据基础。

研究设计与样本

  • 系统综述检索PubMed、Embase、Cochrane Central Register of Controlled Trials和SinoMed,并检索ClinicalTrials.gov、WHO国际临床试验注册平台和StrokeCenter.org。
  • 由4名独立评审者进行研究选择、数据提取和质量评估,文献回顾共识别17项试验、3236例患者及8项在研临床试验。
  • 样本量范围为7至656名受试者。

主要发现

  • 在网络荟萃分析中,静脉溶栓联合机械取栓与更高的独立功能率相关。
  • 静脉溶栓在神经功能方面被排名为最无效的治疗策略,直接机械取栓在全因死亡方面被排名为最不安全的干预。
  • 无论采用何种评估工具,血管内治疗联合静脉溶栓的成功再通率均高于单纯溶栓。

关键数值与推荐

  • 纳入17项试验共3236例患者,样本量7至656例。
  • 干预包括静脉溶栓、静脉溶栓联合机械取栓、静脉溶栓联合动脉内溶栓、单纯动脉内溶栓和单纯机械取栓。
  • 静脉溶栓为最常见的干预,其次为静脉溶栓联合机械取栓。

临床怎么用

  • 对适合溶栓的大血管闭塞急性缺血性卒中患者,可优先考虑静脉溶栓联合机械取栓的再通策略。
  • 直接机械取栓在全因死亡安全性方面排名最差,临床决策时需权衡其安全性。
  • 未来研究应统一有症状颅内出血和再通的定义,以便证据整合。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The optimal recanalization strategy for acute ischemic stroke with large vessel occlusion continues to be an area of active interest. Network meta-analysis can provide insight when direct comparative evidence is lacking. METHODS: A systematic review of the literature using PubMed, Embase, the Cochrane Central Register of Controlled Trials, and SinoMed was performed, and a search was conducted for clinical trials on ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform, and StrokeCenter.org. Four independent reviewers conducted the study selection, data abstraction, and quality assessments. RESULTS: The literature review identified 17 trials including 3236 patients and 8 ongoing clinical trials. Sample sizes ranged from 7 to 656 participants. Intravenous thrombolysis (IVT) was the most common intervention, followed by IVT plus mechanical thrombectomy (MT), IVT plus intraarterial thrombolysis, intraarterial thrombolysis alone, and MT alone. In the pooled network meta-analysis, IVT+MT was associated with a higher rate of independent functioning. In contrast, IVT was ranked as the most ineffective treatment strategy with respect to neurological functions, while direct MT was ranked as the least safe intervention with respect to all-cause mortality. Also, irrespective of assessment tools, endovascular treatment plus IVT led to higher successful recanalization rate than thrombolysis alone. CONCLUSIONS: Compared with other recanalization treatments, IVT+MT seems to be the most effective strategy, without increasing detrimental effects, for thrombolysis-eligible patients with large vessel occlusion-acute ischemic stroke. To improve the current evidentiary basis for recanalization treatment, future trials and real-world studies are warranted and should use unified definitions of symptomatic intracranial hemorrhage and recanalization.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Hui W, Wu C, Zhao W, et al. Efficacy and Safety of Recanalization Therapy for Acute Ischemic Stroke With Large Vessel Occlusion: A Systematic Review. Stroke. 2020. PMID: 32486966. doi:10.1161/STROKEAHA.119.028624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。